FDA Inspection 827719 — S&B Pharma LLC d.b.a. Norac Pharma
The FDA completed an inspection of S&B Pharma LLC d.b.a. Norac Pharma on April 10, 2013 in Azusa, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 10, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Azusa, CA (United States)